References
1 Turagam Mohit K, Velagapudi Poonami, Kocheril
Abraham G. Atrial fibrillation in athletes. Am. J Cardiol
2012;109:296-302.
2 Claessen G, Colyn E, La Gerche A, Koopman P, Alzand
B, Garweg C et al. Long-term endurance sport is a risk factor for
development of lone atrial flutter. Heart 2011;97:918-22
3 Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D,
Casadei B et al. 2016 ESC guidelines for the management of atrial
fibrillation developed in collaboration with EACTS. Eur Heart J
2016;37:2893-2962
4 January CT, Wann LS, Alpert JS, Calkins H, Cigarroa
JE, Cleveland JC Jr et al. 2014 AHA/ACC/HRS guidelines for the
management of patients with atrial fibrillation: a report of the
American College of Cardiology/American Heart Association Task Force on
practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol
2014;64:e1-76
5 Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ,
Chen SA et al. 2012 HRS/EHRA/ECAS Expert consensus statement on catheter
and surgical ablation of atrial fibrillation: recommendations for
patient selection, procedural techniques, patient management and
follow-up, definitions, endpoints, and research trial design. Europace
2012;14:528-606
6 Cappato R, Calkins H, Chen S, Davies W, Iesaka Y,
Kalman J et al. Updated worldwide survey on the methods, efficacy, and
safety of catheter ablation of human atrial fibrillation. Circ Arrhythm
Electrophysiol. 2010;3:32-38
7 Nielsen J, Johannessen A, Raatikainen P, Hindricks
G, Walfridsson H, Kongstad O et al. Radiofrequency ablation as initial
therapy in paroxysmal atrial fibrillation. NEJM 2012;367:1587-95
8 Asad Z, Yousif A, Khan M, Al-Khatib S, Stavrakis S.
Catheter ablation versus medical therapy for atrial fibrillation. Circ.
Arrhtyhm Electrophysiol 2019;12:e007414
9 Berger W, Meulendjiks E, Limpens J, van den Berg N,
Neefs J, Driessen A et al. Persistent atrial fibrillation: a systematic
review and meta-analysis of invasive strategies. Int J Cardiol
2019;278:137-143
10 Kukendrarajah K, Papageorgious N, Jewell P, Hunter
R, Ang R, Schilling R et al. Systematic review and network meta-analysis
of atrial fibrillation percutaneous catheter ablation technologies using
randomized controlled trials. J Cardiovasc Electrophysiol
2020;31:2192-2205
11 Furlanello F, Lupo P, Pittalis M, Foresti S,
Vitali-Serdoz L, Francia P et al. Radiofrequency catheter ablation of
atrial fibrillation in athletes referred for disabling symptoms
preventing usual training schedule and sport competition. J Cardiovasc
Electrophysiol 2008;19:457-62
12 Calvo N, Mont L, Tamborero D, Berruezo A, Viola G,
Guasch E et al. Efficacy of radiofrequency catheter ablation in athletes
with atrial fibrillation in endurance athletes. Europace 2010;12:30-6
13 Koopman P, Nuyens D, Garweg C, La Gerche A, De Buck
S, Van Casteren L et al. Efficacy of radiofrequency catheter ablation in
athletes with atrial fibrillation. Europace 2011;13:1386
14 Decroocq M, Ninni S, Klein C, Machuron F, Verbrugge
E, Klug D et al. No impact of sports practice before or after atrial
fibrillation ablation on procedure efficacy in athletes: a case-control
study. Europace 2019;21:1833-42
15 Mandsager K, Dermot P, Mohamed D, Baranowski B,
Saliba W, Tarakji K et al. Outcomes of pulmonary vein isolation in
athletes. J Am Coll Cardiol EP 2020;6:1265-74
16 Lavie C, Pandey A, Lau D, Alpert M, Sanders P.
Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis:
effects of weight loss and exercise. J Am Coll Cardiol 2017;70:2022-35
17 Pouwels S, Topal B, Knook M, Celik A, Sundbom M,
Ribeiro R et al. Interaction of obesity and atrial fibrillation: an
overview of pathophysiology and clinical management. Expter Rev
Cardiovasc Ther 2019;17:209-223
18 Middeldorp M, Pathak R, Meredith M, Mehta A,
Elliott A, Mahajan R et al. PREVEntion and regressive Effect of
weight-loss and risk factor modification on Atrial Fibrillation: the
REVERSE-AF study. Europace 2018;20:1929-35
19 Njoku A, Kannabhiran M, Arora R, Reddy P,
Gopinatthannair R, Lakkireddy D et al. Left atrial volume predicts
atrial fibrillation recurrence after radiofrequency ablation: a
meta-analysis. Europace 2018;20:33-42
20 Wilhelm M. Atrial fibrillation in endurance
athletes. Eur J Prev Cardiol 2014;21:1040-48
21 Swanson DR. Atrial fibrillation in athletes:
implicit literature-based connections suggest that overtraining and
subsequent inflammation may be a contributore mechanism. Med Hypothesis
2006;66:1085-92
22 Engelmann MD, Svendsen JH. Inflammation in the
genesis and perpetuation of atrial fibrillation. Eur Heart J
2005;26:2083-92
23 Calvo N, Brugada J, Sitges M, Mont L. Atrial
fibrillation and atrial flutter in athletes. Br J Sports Med
2012;46:i37-i43
24 Pontoppidan J, Nielsen JC, Poulsen SH, Jensen HK,
Walfridsson H, Pedersen AK et al. Prophylactic cavotricuspid isthmus
block during atrial fibrillation ablation in patients without atrial
flutter: a randomized controlled trial. Herat 2009;95:994-999
25 Mesquita J, Ferreira AM, Cavaco D, Carmo P, Maderia
M, Freitas P et al. Impact of prophylactic cavotricuspid isthmus
ablation in atrial fibrillation recurrence after a first pulmonary vein
isolation procedure. Int J Cardiol 2018;259:82-87
26 Lee WC, Fang HY, Chen HC, Chen YL, Tsai TH, Pan KL
et al. Additional cavotricuspid isthmus block ablation may not improve
the outcome of atrial fibrillation ablation. Pacing Clin Electrophysiol
2019;42:1421-28
27 Romero J, Patel K, Briceno D, Lakkireddy D, Gabr M,
Diaz JC et al. Cavotricuspid isthmus line in patients undergoing
catheter ablation of atrial fibrillation with or without history of
typical atrial flutter: a meta-analysis. J Cardiovasc Electrophysiol
2020;31:1987-95
28 Heidbuchel H, Adami PE, Antz M, Braunschweig F,
Delise P, Scherr D et al. Recommendations for participation in
leisure-time physical activity and competitive sports in patients with
arrhythmias and potentially atthrythmogenic conditions: Part 1:
Supraventricular arrhythmias. Eur J Prev Cardiol 2020; doi: 10.1177/
2047487320925635